slide1 n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
District of Columbia Department of Health PowerPoint Presentation
Download Presentation
District of Columbia Department of Health

Loading in 2 Seconds...

play fullscreen
1 / 35

District of Columbia Department of Health - PowerPoint PPT Presentation


  • 187 Views
  • Uploaded on

District of Columbia Department of Health. Health Regulation and Licensing Administration Board of Pharmacy and Pharmaceutical Control. Patricia M. D’Antonio, RPh, MS, MBA,CGP Executive Director, Board of Pharmacy Program Manager, Pharmaceutical Control September 28, 2013. Organization.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'District of Columbia Department of Health' - ginger


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

District of Columbia

Department of Health

Health Regulation and Licensing AdministrationBoard of Pharmacy and Pharmaceutical Control

Patricia M. D’Antonio, RPh, MS, MBA,CGP

Executive Director, Board of Pharmacy

Program Manager, Pharmaceutical Control

September 28, 2013

organization
Organization
  • Health Professions Licensing Administration – Board of Pharmacy
      • Pharmacists
        • Authority to Immunize
      • Pharmaceutical Detailers
      • Pharmacy Interns
      • Pharmacy Technicians (Bill passed; regulations pending)
board of pharmacy
Board of Pharmacy
  • The mission of Board of Pharmacy is to protect and improve the public health through the efficient and effective regulation of the practice of Pharmacy and Pharmaceutical Detailing; through the licensure of Pharmacist, Pharmaceutical Detailers and Pharmacy Interns.
  • 7 Members
    • 5 pharmacists
    • 2 consumers (1 space vacant)
    • Daphne Bernard, PharmD Chairperson
pharmaceutical control division
Pharmaceutical Control Division
  • Health Regulation and Licensing Administration – Division of Food, Drug, Radiation and Community Hygiene
    • Conduct routine and complaint driven inspections of pharmacy operations of health facilities
    • Investigate reports of contaminated or suspect drugs or improper distribution of controlled substances
    • Investigate unusual or suspicious reports in drug supply or in the handling of the drug by the professional
regulated facilities include
Regulated Facilities Include:

Substance Abuse Treatment Programs

Animal Clinics

Dialysis Centers

Ambulatory Surgical Centers

Controlled Substance Registration for Professionals

  • Pharmacies
    • Resident
    • Non-Resident
  • Researchers/Teaching Institutions
  • Wholesalers/Distributors/Manufacturers
  • Fire/EMS
  • Medical Examiner
liaison role
Liaison Role

Between District and Federal entities:

  • Food and Drug (FDA)
  • Drug Enforcement Administration (DEA)
  • Health Human Service (HHS)
  • Consumer Protection Agency
  • And others involving regulatory

control matters related to medications

pharmacy law and regulations
Pharmacy Law and Regulations
  • DC Code Title 47, Section 2885.01 Pharmacy
  • DC Code Title 48, Section 701-901

Pharmacy related laws

  • Federal Law
    • Code of Federal Regulations (CFR) 21, Part 1
      • Section 1300 - Drugs
pharmacy law and regulations1
Pharmacy Law and Regulations
  • DCMR Title 22 Public Health & Medicine

Chapter 4 – Distribution, Manufacturer, or Wholesaler of Drugs

Chapter 5 – Safe Disposal of Medications

Chapter 10 – Controlled Substance Registration for Manufacturers, Distributors, and Dispensers

Chapter 12 – Controlled Substances

Chapter 13 – Prescription and Distribution

Chapter 15 – Inspections

Chapter 19 – Pharmacies

laws regulations
Laws/Regulations
  • DCMR Title 17 Business, Industry Professions
    • Chapter 40 – Health Occupations, General Rules
    • Chapter 41 – Health Occupations, Administrative Procedures
    • Chapter 65 – Pharmacists, Pharmacy Interns
    • Chapter 83 – Pharmaceutical Detailers
    • Chapter 85 – Criminal Background Check
other regulations of interest
Other Regulations of Interest

Title 22 DCMR

Chapter 20 – Hospital and Clinics, Pharmacy Services

Chapter 31 – Health Care and Community Residence Facilities

Chapter 32 – Nursing Facilities, Pharmaceutical Services

Chapter 35 – Group Homes

where can i find this
Where can I find this?
  • DC Municipal Regulations and DC Register www.dcregs.dc.gov
    • Subscribe
    • My favorites
  • DC Board of Pharmacy webpage
    • http://doh.dc.gov/bop
  • DC Pharmaceutical Control webpage
    • http://doh.dc.gov/pcd
what s new
What’s New?
  • Criminal Background Check
  • Immunization Updates
  • Safe Disposal of Unused Pharmaceuticals
  • Collaborative Practice
  • Pharmacy Technician
  • Prescription Drug Monitoring Program
criminal background check
Criminal Background Check
  • As of January 3, 2011
  • Initial, renewal or reinstatement license
  • All health care professionals
  • FBI and Local
  • Repeat every 4 years
  • Through Morpho Trust Services
  • In District/Out of District Process
  • http://doh.dc.gov/cbc
immunization
Immunization
  • 17 DCMR Section 6512
  • Effective, June 8, 2012
  • immunize patients twelve (12) years and older with parental consent or patients eighteen (18) years and older that present valid identification for specific vaccinations by protocol
immunization1
Immunization
  • Obtain written protocol for the vaccinations from a physician
  • Report vaccine administration to the physician listed on the Vaccination Protocol and to the patient’s primary care physician.
  • Adverse events reporting requirements
    • Pharmaceutical Control Division
    • Director of the Department of Health
    • within 48 hours of the discovery of occurrence
immunization2
Immunization
  • Hepatitis
  • Shingles
  • Human Papillomavirus
  • Tetanus
  • Tdap
  • Meningococcal
  • HeamophilusInfluenzae
  • Pneumococcal
  • Influenza including but not limited to H1N1 and other epidemic vaccinations specified by the World Health Organization or the Center for Disease Control at the time of vaccination
immunization3
Immunization
  • Registration with the Board required
    • not new but seems to cause confusion
    • FAQs on Board of Pharmacy website
    • Pharmacist License not Facility License
safe disposal of unused pharmaceuticals
Safe Disposal of Unused Pharmaceuticals
  • Unused Pharmaceutical Safe Disposal Act of 2009 (legislation)
  • Applies to Health Care Facilities
  • Facilities shall not disposed of unused pharmaceuticals by flushing the product down a drain or any method that uses the public sewer system
safe disposal of unused pharmaceuticals1
Safe Disposal of Unused Pharmaceuticals
  • Subject to a civil fine of up to one thousand dollars ($1,000) per occurrence; and
  • Required to submit to the Board of Pharmacy, or its designee, a mitigation plan designed to prevent further such occurrences within thirty (30) days of receipt of a request for the mitigation plan
collaborative practice
Collaborative Practice
  • Collaborative Care Expansion Amendment Act of 2012 passed in May 31, 2013
  • Regulations pending from Board of Pharmacy and Board of Medicine
  • Voluntary written agreement
  • Between a licensed pharmacist and a licensed physician or another health practitioner with independent prescriptive authority
collaborative practice1
Collaborative Practice
  • Defines the scope of practice between the licensed pharmacist and licensed physician, or other health practitioner,
    • Licensed by a District health occupation board
  • Initiation, modification, or discontinuation of a drug therapy regimen
collaborative practice agreements
Collaborative Practice Agreements
  • Specification of the drug therapy to be provided and any tests that may be necessarily incident to its provision;
  • Conditions for initiating, modifying, or discontinuing a drug therapy; and
  • Directions concerning the monitoring of a drug therapy and the conditions that would warrant a modification
  • Establish policies and procedures for approving, disapproving, and revoking collaborative practice agreements.
pharmacy technician
Pharmacy Technician
  • Pharmacy Technician Amendment Act
    • Passed July 19, 2013
  • 17 years of age
  • A high school diploma or its equivalent, or has passed a Board-approved examination that proves that he or she has achieved competency in the educational skills required to perform the function of a pharmacy technician; and
pharmacy technician1
Pharmacy Technician
  • A current certification from the Pharmacy Technician Certification Board, the National Health Career Association, or another national or state certifying organization approved by the Board; or
  • Successfully completed one of the following types of pharmacy training programs, which shall include a Board-approved exam:
technician training programs
Technician Training Programs
  • (i) A national, regional, or state accredited pharmacy technician training program recognized by the Board;
  • (ii) A pharmacy technician program at a college or university that is accredited by an accrediting body recognized by the Secretary of the United States Department of Education or the Council on Postsecondary Accreditation
  • (iii) An employer-based pharmacy technician training program recognized by the Board that includes within a one-year period a minimum of 160 hours of training, including theoretical and practical instruction; or
  • (iv) A pharmacy technician program that meets the guidelines of the American Society of Health-System Pharmacists, is licensed by the District of Columbia Educational Licensure Commission, and has certified to the Board its intent to pursue accreditation upon becoming eligible to do so.
pharmacy technician2
Pharmacy Technician
  • Grandfather Clause
  • Defines the roles of ancillary personnel
  • Addresses supervision responsibilities of a pharmacist
  • Regulations pending Board of Pharmacy
    • Legislation provides one year
    • Monitor communications and DC Register for Proposed Regulations
prescription drug monitoring program
Prescription Drug Monitoring Program
  • Tool for practitioners to review prior to writing controlled substance prescription
  • Legislation introduced in 2012
  • Hearing held in July 2013
  • Expected passage by end of 2013
findings on inspection
Findings on Inspection
  • Failure to document administration and/or wasting of CSII substances
  • Failure to obtain drugs from an approved supplier
  • Failure to conduct CSII audit as indicated
  • Medication Administration Records (MARs) not consistently reflecting current date and time
  • Physician signature log missing DC Controlled Substance and DEA numbers and respective expiration dates
compounding
Compounding
  • preparation, mixing, assembling, packaging, or labeling of a drug or device
  • result of a practitioner’s prescription drug order or for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing
  • in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns
manufacturing
Manufacturing
  • prepare, produce, propagate, compound, convert, process, or package a drug, either directly or indirectly, by extraction from a substance of natural origin, or independently by means of chemical synthesis
manufacturing1
Manufacturing
  • any packaging or repackaging of the substance or drug; labeling or relabeling of any drug package or container to further distribution from the original place of manufacture to the person who makes final delivery, distribution, or sale to the ultimate consumer or user
accessrx prescription drug marketing costs
AccessRxPrescription Drug Marketing Costs
  • manufacturers and labelers of prescription drugs who engage in marketing in District report their costs for pharmaceutical drug marketing in the District
  • 2011 report $83.7M (158 companies)
  • Impact Reports
    • Antipsychotic Use in Children (2012)
    • Antipsychotic Use in the Elderly (2013)
future
Future
  • Clarification of Student Intern requirements
  • Prescription Drug Monitoring Program
  • Manufacturer/Distributor Regulations
  • Compounding Regulations
board of pharmacy meeting
Board of Pharmacy Meeting

First Thursday of every month

9:30am

899 North Capitol Street, NE

2nd Floor Conference Room

Open to the Public

slide35

Health Regulation and Licensing AdministrationBoard of Pharmacy and Pharmaceutical Control

899 North Capitol Street, NE

2nd Floor

Washington DC 20002

Phone Number: 202-727-9856

patricia.dantonio@dc.gov